Spero Therapeutics Stock (NASDAQ: SPRO) stock price, news, charts, stock research, profile.
Open | $1.37 |
Close | $1.33 |
Volume / Avg. | 129.39K / 114.00K |
Day Range | $1.32 - $1.37 |
52 Wk Range | 0.99 - 1.89 |
Market Cap | $71.89M |
P/E Ratio | 3.99 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 0.92% |
Days to Cover | 3.04 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.
Other companies in Spero Therapeutics’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX), Armata Pharmaceuticals (AMEX:ARMP) and Gritstone Bio (NASDAQ:GRTS).
There is no analysis for Spero Therapeutics to provide a consensus price target.
The stock price for Spero Therapeutics (NASDAQ: SPRO) is $1.33 last updated September 20, 2024 at 4:02 PM EDT.
A quarterly cash dividend of 0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2015 to stockholders of record on September 16, 2015.
Spero Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Spero Therapeutics.
Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.